Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies.

ABSTRACT:

Background

Patients with restrictive or hypertrophic cardiomyopathy (RCM/HCM) and congenital heart disease (CHD) do not derive clinical benefit from inotropes and mechanical circulatory support. Concerns were expressed that the new heart allocation system implemented in October 2018 would disadvantage these patients. This paper aimed to examine the impact of the new adult heart allocation system on transplantation and outcomes among patients with RCM/HCM/CHD.

Methods

We identified adult patients with RCM/HCM/CHD in the United Network for Organ Sharing (UNOS) database who were listed for or received a cardiac transplant from April 2017-June 2020. The cohort was separated into those listed before and after allocation system changes. Demographics and recipient characteristics,

SUBMITTER: Chouairi F 

PROVIDER: S-EPMC7924739 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature